Emergent BioSolutions (EBS) Proxy Filing summary

Executive summary

• Annual meeting scheduled for April 30, 2025, at 9:00 a.m. ET via virtual meeting; voting deadline is April 29, 2025, at 11:59 p.m. ET.

Voting matters and shareholder proposals

• Shareholders will vote on three Class I director nominees, auditor ratification, and an advisory vote on 2024 named executive officer compensation; the board recommends voting For each item.

Board of directors and corporate governance

• Keith Katkin, Ronald Richard, and Kathryn Zoon, Ph.D., are nominated as Class I directors for terms expiring at the 2028 Annual Meeting, serving until successors are elected and qualified.